VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Tuesday, December 30, 2025
Stock Comparison
OMRON Corporation vs Amgen Inc.
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
OMRON Corporation
6645 · Tokyo Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into OMRON Corporation's moat claims, evidence, and risks.
View 6645 analysisAmgen Inc.
AMGN · Nasdaq Stock Market
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Comparison highlights
- Moat score gap: Amgen Inc. leads (70 / 100 vs 59 / 100 for OMRON Corporation).
- Segment focus: OMRON Corporation has 5 segments (45% in Industrial Automation Business (IAB)); Amgen Inc. has 3 segments (80.1% in Core Innovative Medicines).
- Primary market structure: Oligopoly vs Competitive. Pricing power: Moderate vs Moderate.
- Moat breadth: OMRON Corporation has 7 moat types across 4 domains; Amgen Inc. has 5 across 3.
Primary market context
OMRON Corporation
Industrial Automation Business (IAB)
Industrial automation components and factory automation solutions (sensors, controllers, safety, robotics, OT/IT services)
Global
Manufacturers and machine builders (B2B)
Automation supplier + solutions/services provider
45%
Amgen Inc.
Core Innovative Medicines
Branded biopharmaceutical therapies for common diseases (bone health, inflammation, oncology, cardiovascular and other specialty areas)
Global
Payers, providers, and pharmacies
Drug developer/manufacturer
80.1%
Side-by-side metrics
Moat coverage
Shared moat types
OMRON Corporation strengths
Amgen Inc. strengths
Segment mix
OMRON Corporation segments
Full profile >Industrial Automation Business (IAB)
Oligopoly
Healthcare Business (HCB)
Competitive
Social Systems, Solutions and Service Business (SSB)
Oligopoly
Device and Module Solutions Business (DMB)
Competitive
Data Solution Business (DSB)
Oligopoly
Amgen Inc. segments
Full profile >Core Innovative Medicines
Competitive
Rare Disease Portfolio (Horizon + others)
Quasi-Monopoly
Biosimilars
Oligopoly
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.